Literature DB >> 11940696

Seasonal variation in immune measurements and MRI markers of disease activity in MS.

J Killestein1, M H G Rep, J F Meilof, H J Adèr, B M J Uitdehaag, F Barkhof, R A W van Lier, C H Polman.   

Abstract

BACKGROUND: The exact mechanisms by which T cells contribute to MS progression are not known. Recently, the results of cross-sectional studies suggested seasonal variation of both interferon (IFN)-gamma production and the number of active MRI lesions in MS.
OBJECTIVE: To investigate whether seasonal fluctuations of IFN-gamma and active MRI lesions could be confirmed and whether any correlations could be detected.
METHODS: Data were analyzed from a group of 28 MS patients in whom detailed longitudinal monitoring of both immune function and MRI measurements had taken place.
RESULTS: Significant seasonal variation was observed in T-cell activation as measured by the ability of T cells to secrete the pro-inflammatory cytokines tumor necrosis factor-alpha and IFN-gamma. Maximum values were found in samples obtained during autumn. Even though clear fluctuations were observed, no significant seasonal variation could be detected in the number of active MRI lesions. Fluctuations of in vitro IFN-gamma secretion correlated weakly with changes in active MRI lesions.
CONCLUSIONS: The finding of seasonal variation of immune function in serially MRI-monitored MS patients suggests an environmental role in T-cell activation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11940696     DOI: 10.1212/wnl.58.7.1077

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  12 in total

Review 1.  Role of vitamin D in immune responses and autoimmune diseases, with emphasis on its role in multiple sclerosis.

Authors:  Hong-Liang Zhang; Jiang Wu
Journal:  Neurosci Bull       Date:  2010-12       Impact factor: 5.203

2.  Seasonal prevalence of MS disease activity.

Authors:  D S Meier; K E Balashov; B Healy; H L Weiner; C R G Guttmann
Journal:  Neurology       Date:  2010-08-31       Impact factor: 9.910

3.  Effect of seasonal variation on the clinical course of chronic hepatitis B.

Authors:  Shi-Jun Zhang; Ze-Xiong Chen; Kai-Ping Jiang; Wei-Kang Wu; Cui-Yi Zhang; Yan-Li Gu
Journal:  J Gastroenterol       Date:  2006-12-08       Impact factor: 7.527

Review 4.  Seasonal and monthly variation in multiple sclerosis relapses: a systematic review and meta-analysis.

Authors:  Fardin Nabizadeh; Parya Valizadeh; Maryam Yazdani Tabrizi; Kimia Moayyed; Niousha Ghomashi; Omid Mirmosayyeb
Journal:  Acta Neurol Belg       Date:  2022-09-28       Impact factor: 2.471

5.  A seasonal periodicity in relapses of multiple sclerosis? A single-center, population-based, preliminary study conducted in Bologna, Italy.

Authors:  Fabrizio Salvi; Ilaria Bartolomei; Michael H Smolensky; Angelo Lorusso; Elena Barbarossa; Anna Maria Malagoni; Paolo Zamboni; Roberto Manfredini
Journal:  BMC Neurol       Date:  2010-11-01       Impact factor: 2.474

6.  Leptin enhances the release of cytokines by peripheral blood mononuclear cells from relapsing multiple sclerosis patients.

Authors:  Giovanni Frisullo; Francesco Angelucci; Massimiliano Mirabella; Marcella Caggiula; Katia Patanella; Viviana Nociti; Pietro Attilio Tonali; Anna Paola Batocchi
Journal:  J Clin Immunol       Date:  2004-05       Impact factor: 8.317

Review 7.  Association between seasonal factors and multiple sclerosis.

Authors:  Abdulla Watad; Shir Azrielant; Alessandra Soriano; Danielle Bracco; Arsalan Abu Much; Howard Amital
Journal:  Eur J Epidemiol       Date:  2016-05-25       Impact factor: 8.082

8.  Seasonal changes in activities of human neutrophils in vitro.

Authors:  Magdalena Klink; Katarzyna Bednarska; Edyta Blus; Michal Kielbik; Zofia Sulowska
Journal:  Inflamm Res       Date:  2011-09-29       Impact factor: 4.575

9.  Vitamin D supplementation for patients with multiple sclerosis treated with interferon-beta: a randomized controlled trial assessing the effect on flu-like symptoms and immunomodulatory properties.

Authors:  Daniel Golan; Basheer Halhal; Lea Glass-Marmor; Elsebeth Staun-Ram; Orit Rozenberg; Idit Lavi; Sara Dishon; Mira Barak; Sophia Ish-Shalom; Ariel Miller
Journal:  BMC Neurol       Date:  2013-06-14       Impact factor: 2.474

10.  Immunologic and MRI markers of the therapeutic effect of IFN-β-1a in relapsing-remitting MS.

Authors:  Yazhong Tao; Xin Zhang; Robert Zivadinov; Michael G Dwyer; Cheryl Kennedy; Niels Bergsland; Deepa Ramasamy; Jacqueline Durfee; David Hojnacki; Brooke Hayward; Fernando Dangond; Bianca Weinstock-Guttman; Silva Markovic-Plese
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.